Literature DB >> 2370093

In vitro studies on the effect of certain natural products against hepatitis B virus.

R Mehrotra1, S Rawat, D K Kulshreshtha, G K Patnaik, B N Dhawan.   

Abstract

Picroliv (active principle from Picrorrhiza kurroa), its major components picroside I, catalpol, kutkoside I, kutkoside, andrographolide (active constituent of Andrographis paniculata), silymarin and Phyllanthus niruri extract were tested for the presence of anti hepatitis B virus surface antigen (anti HBs) like activity. HBsAg positive serum samples obtained from hepatitis B virus (HBV) associated acute and chronic liver diseases and healthy HBsAg carriers were used to evaluate the anti-HBs like activity of compounds/extract. The latter were mixed with serum samples and incubated at 37 degrees C overnight followed by HBsAg screening in the Elisa system. A promising anti-HBsAg like activity was noted in picroliv (and its major components) catalpol, P. niruri which differed from the classical viral neutralization. Picroliv also inhibited purified HBV antigens (HBsAg and HBsAg) prepared from healthy HBsAg carriers. The in vitro testing system appears to be a suitable model to identify an agent active against HBV, prior to undertaking detailed studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370093

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  11 in total

1.  Bioactive Compounds from Medicinal Plants in Myanmar.

Authors:  Nwet Nwet Win; Hiroyuki Morita
Journal:  Prog Chem Org Nat Prod       Date:  2021

Review 2.  Nain-e Havandi Andrographis paniculata present yesterday, absent today: a plenary review on underutilized herb of Iran's pharmaceutical plants.

Authors:  Alireza Valdiani; Mihdzar Abdul Kadir; Soon Guan Tan; Daryush Talei; Mohd Puad Abdullah; Sonia Nikzad
Journal:  Mol Biol Rep       Date:  2011-12-24       Impact factor: 2.316

3.  Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis.

Authors:  Preetha Anand; Ajaikumar B Kunnumakkara; Kuzhuvelil B Harikumar; Kwang Seok Ahn; Vladimir Badmaev; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

4.  Acute toxicity studies of aqueous leaf extract of Phyllanthus niruri.

Authors:  George Awuku Asare; Phyllis Addo; Kwasi Bugyei; Ben Gyan; Samuel Adjei; Lydia Serwaa Otu-Nyarko; Edwin Kwame Wiredu; Alexander Nyarko
Journal:  Interdiscip Toxicol       Date:  2011-12

5.  NGS Transcriptomes and Enzyme Inhibitors Unravel Complexity of Picrosides Biosynthesis in Picrorhiza kurroa Royle ex. Benth.

Authors:  Kirti Shitiz; Neha Sharma; Tarun Pal; Hemant Sood; Rajinder S Chauhan
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

6.  Phytochemical studies for quantitative estimation of iridoid glycosides in Picrorhiza kurroa Royle.

Authors:  Phalisteen Sultan; Arif Jan; Qazi Pervaiz
Journal:  Bot Stud       Date:  2016-02-26       Impact factor: 2.787

7.  A Picrorhiza kurroa derivative, picroliv, attenuates the development of dextran-sulfate-sodium-induced colitis in mice.

Authors:  De-Kui Zhang; Jian-Jie Yu; Yu-Min Li; Li-Na Wei; Yi Yu; Yan-Hu Feng; Xiang Wang
Journal:  Mediators Inflamm       Date:  2012-10-16       Impact factor: 4.711

8.  Hepatoprotective and antiviral efficacy of Acacia mellifera leaves fractions against hepatitis B virus.

Authors:  Ahmed H Arbab; Mohammad K Parvez; Mohammed S Al-Dosari; Adnan J Al-Rehaily; Mohammed Al-Sohaibani; Elwaleed E Zaroug; Mansour S AlSaid; Syed Rafatullah
Journal:  Biomed Res Int       Date:  2015-04-09       Impact factor: 3.411

9.  Micronucleus Test of Picrorrhiza Rhizoma Aqueous Extract in Bone Marrow Cells of Male ICR Mice.

Authors:  In-Kwon Chung; Woo-Hyun Cheon; Sae-Kwang Ku
Journal:  Toxicol Res       Date:  2011-06

10.  In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus.

Authors:  Ahmed Hassan Arbab; Mohammad Khalid Parvez; Mohammed Salem Al-Dosari; Adnan Jathlan Al-Rehaily
Journal:  Exp Ther Med       Date:  2017-05-31       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.